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ABSTRACT: Vitamin B12 deficiency usually occurs in exclusively breastfed infants whose mothers 
have pernicious anaemia or are vegetarian. Early treatment of vitamin B12 deficiency in infants can 
prevent potentially neurologic sequelae. A male child aged 13 months has been hospitalized due to 
failure to thrive, feeding problems, pallor, weakness and hypotonia. During the pregnancy mother did 
not eat meat and during lactation she also excluded eggs and milk. The child was exclusively 
breastfed. Laboratory investigations showed a haemoglobin level of 3.5 g/dL, haematocrit 10%, red 
blood cell count of 0.99 × 1012/L, white blood cell count of 4.23 × 109/L and platelet count of 55 × 
109/L. Vitamin B12 level was low. A bone marrow aspiration finding was consistent with megaloblastic 
anaemia. The magnetic resonance imaging showed brain atrophy. Vitamin B12 in a dose of 10µg per 
kg was applied intramuscularly daily for 2 weeks, then once weekly. Three days after initiating B12 
vitamin therapy there was an improvement in the blood count with the gradual improvement of 
neurological state. Vitamin B12 deficiency is a treatable cause of pancytopenia and neurological 
dysfunction in children and should be considered as differential diagnosis in an infant with neurological 
symptoms. 




Vitamin B12 (cobalamin) is essential for 
folate metabolism and DNA synthesis, ac-
ting as a cofactor for key enzymatic 
reactions (Roumeliotis et al., 2012). 
Vitamin B12 is not synthesized by the 
body and must therefore be ingested 
through diet. In the stomach, it binds to 
intrinsic factor, a protein synthesized by 
parietal cells. The B12–intrinsic factor 
complex is then absorbed into the circula-
tion in the distal ileum (Roumeliotis et al., 
2012). 
Worldwide, vitamin B12 deficiency is an 
important cause of infant morbidity, espe-
cially in the Indian subcontinent, Mexico, 
Central America and certain regions of 
Africa (Roumeliotis et al., 2012). 
Childhood vitamin B12 deficiency is pro-
bably significantly more frequent than 
usually thought. Various studies carried 
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out in the developing world or in countries 
where vegetarian diets are common have 
shown that a large number of mothers and 
children have low serum vitamin B12 
levels that closely correlate with mild 
clinical problems mainly involving the cen-
tral nervous system (Guez et al., 2012). 
Vitamin B12 deficiency usually occurs in 
exclusively breastfed infants whose mo-
thers have pernicious anaemia or are ve-
getarian leading to low body stores of vita-
min B12 in the infant at birth and insuf-
ficient amounts of the vitamin in the breas-
tmilk. Clinical manifestation of vitamin B12 
deficiency in infants appears between 4 
and 12 months of age and includes mac-
rocytic anaemia, weakness, lethargy, irri-
tability, feeding difficulties, failure to thrive, 
and neurodevelopmental regression (Ko-
caoglu et al.; 2014, Goraya et al., 2015). 
The position statement on vegetarian diets 
points out that well-planned vegan and 
vegetarian diets are appropriate for all sta-
ges of the life cycle and offer a number of 
nutritional benefits, but it also notes that 
the use of fortified foods or supplements 
can be helpful in meeting dietary recom-
mendations, especially in diets that com-
pletely exclude animal products (Elmadfa 
and Singer, 2009). 
Early treatment of vitamin B12 deficiency 
in infants can prevent potentially neurolo-
gic and developmental sequelae (Roume-
liotis et al., 2012). 
CASE REPORT 
A male child aged 13 months was hospi-
talized due to failure to thrive, feeding pro-
blems, pallor, weakness and hypotonia. 
The child was born in a term, at home and 
was not vaccinated. During the pregnancy 
mother did not eat meat and during lacta-
tion she also excluded eggs and milk. She 
did not use any supplementation. The 
child was exclusively breastfed. At the age 
of 6 months the mother attempted to intro-
duce solid food, but the child refused. De-
ficiency of vitamin B12 was confirmed by 
subsequent examination of the mother. 
One child’s grandmother suffered from a-
naemia and was receiving B12 vitamin 
therapy while the other one had leu-
kaemia. The child manifested a neurode-
velopmental delay with a loss in body 
weight of 3.100 g for 4 months. On admis-
sion to the hospital he was pale with a 
generalized hypotonia and systolic mur-
mur grade 2. The liver edge was 2.5 cm 
below the costal margin. The splenic tip 
was palpable. His weight was 8,900 g 
(3rdpercentile), length 79 cm (3rdper-
centile), head circumference 46 cm 
(50thpercentile). Laboratory investigations 
showed a haemoglobin level of 3.5 g/dL, 
haematocrit 10%, red blood count of 0.99 
× 1012/L with 3.9% reticulocytes, white blo-
od count of 4.23 × 109/L and platelet count 
of 55 × 109/L. The mean corpuscular vo-
lume (MCV) was 102.5 fL. Foetalhaemo-
globin was 2.1%, serum iron 39.1 µmol/L 
(range 7.2-17.9), unsaturated iron binding 
capacity (UIBC) 18.5 µmol/L (range 27.8-
63.6), total iron binding ca-pacity (TIBC) 
57.6 µmol/L (range 39.4-80.6), serum 
ferritin 159.3 µg/L (range15-300). Homo-
cysteine level was 10.8 µmol/L (range 5-
12). LDH was elevated - 18.54 ukat/L 
(range 0-5.73). Total bilirubin was 42.2 
µmol/L (range 0.01-21), direct bilirubin 9.1 
µmol/L (range 0-5) and indirect bilirubin 
33.3 µmol/L (range 0.01-16). Direct Co-
ombs test was negative. Serum vitamin 
B12 level was 61.2 pmol/L (range 138-
652) and serum folate level 34.5 nmol/L 
(range 7-45.3).The blood smear showed 
anisocytosis with regular white blood cells 
and platelets. A bone marrow aspiration 
showed morphological changes consistent 
with megaloblastic anaemia. Immunofeno-
typing revealed no pathological hemato-
poietic cells. Karyotype was normal. The 
echocardiographic finding was normal. 
The computerized tomography (CT) and 
magnetic resonance imaging (MRI) of the 
endocranium showed global parenchymal 
reductive changes with consecutive en-
largement of ventricles (Figs. 1, 2). Psy-
chological testing revealed a delay in psy-
chical development. 
During the hospitalization the child re-
ceived a transfusion of filtered red blood 
cells three times and a transfusion of pla-
telet concentrates two times. After B12 de-
ficiency was diagnosed, vitamin B12 the-
rapy started. Vitamin B12 in a dose of 10 
µg per kg was applied intramuscularly 
daily for 2 weeks, then once weekly. 
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Figure 1. Magnetic resonance imaging (MRI) of the endocranium (MRI 1.5 T Signa HDx 
General Electric Medical Systems) - global parenchymal reductive changes with consecutive 
enlargement of ventricles 
 
 
Figure 2. The computerized tomography (CT) of the endocranium - brain atrophy 
 
Table 1. 
Admission and follow-up clinical and laboratory data  
Parameter On admission to the hospital 
At the end of 
hospitalisation 







unable to sit or 
stand 
mild hypotonia, 
unable to sit or 
stand 
mild hypotonia, 
able to sit, unable 
to stand 
adequate tonus, 
able to sit and 
stand 
Haemoglobin 
(g/dL) 3.5 13.6 15.8 12.9 
MCV (fL) 102.5 88.9 79.9 74.8 
White blood cell 
count 
(cells x 109) 
4.23 11.8 5.4 4.7 
Platelet count 
(cells x 109) 55 248 318 359 
Serum vitamin 
B12 (pmol/L) 61.2 >1475 >1475 >1475 
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out in the developing world or in countries 
where vegetarian diets are common have 
shown that a large number of mothers and 
children have low serum vitamin B12 
levels that closely correlate with mild 
clinical problems mainly involving the cen-
tral nervous system (Guez et al., 2012). 
Vitamin B12 deficiency usually occurs in 
exclusively breastfed infants whose mo-
thers have pernicious anaemia or are ve-
getarian leading to low body stores of vita-
min B12 in the infant at birth and insuf-
ficient amounts of the vitamin in the breas-
tmilk. Clinical manifestation of vitamin B12 
deficiency in infants appears between 4 
and 12 months of age and includes mac-
rocytic anaemia, weakness, lethargy, irri-
tability, feeding difficulties, failure to thrive, 
and neurodevelopmental regression (Ko-
caoglu et al.; 2014, Goraya et al., 2015). 
The position statement on vegetarian diets 
points out that well-planned vegan and 
vegetarian diets are appropriate for all sta-
ges of the life cycle and offer a number of 
nutritional benefits, but it also notes that 
the use of fortified foods or supplements 
can be helpful in meeting dietary recom-
mendations, especially in diets that com-
pletely exclude animal products (Elmadfa 
and Singer, 2009). 
Early treatment of vitamin B12 deficiency 
in infants can prevent potentially neurolo-
gic and developmental sequelae (Roume-
liotis et al., 2012). 
CASE REPORT 
A male child aged 13 months was hospi-
talized due to failure to thrive, feeding pro-
blems, pallor, weakness and hypotonia. 
The child was born in a term, at home and 
was not vaccinated. During the pregnancy 
mother did not eat meat and during lacta-
tion she also excluded eggs and milk. She 
did not use any supplementation. The 
child was exclusively breastfed. At the age 
of 6 months the mother attempted to intro-
duce solid food, but the child refused. De-
ficiency of vitamin B12 was confirmed by 
subsequent examination of the mother. 
One child’s grandmother suffered from a-
naemia and was receiving B12 vitamin 
therapy while the other one had leu-
kaemia. The child manifested a neurode-
velopmental delay with a loss in body 
weight of 3.100 g for 4 months. On admis-
sion to the hospital he was pale with a 
generalized hypotonia and systolic mur-
mur grade 2. The liver edge was 2.5 cm 
below the costal margin. The splenic tip 
was palpable. His weight was 8,900 g 
(3rdpercentile), length 79 cm (3rdper-
centile), head circumference 46 cm 
(50thpercentile). Laboratory investigations 
showed a haemoglobin level of 3.5 g/dL, 
haematocrit 10%, red blood count of 0.99 
× 1012/L with 3.9% reticulocytes, white blo-
od count of 4.23 × 109/L and platelet count 
of 55 × 109/L. The mean corpuscular vo-
lume (MCV) was 102.5 fL. Foetalhaemo-
globin was 2.1%, serum iron 39.1 µmol/L 
(range 7.2-17.9), unsaturated iron binding 
capacity (UIBC) 18.5 µmol/L (range 27.8-
63.6), total iron binding ca-pacity (TIBC) 
57.6 µmol/L (range 39.4-80.6), serum 
ferritin 159.3 µg/L (range15-300). Homo-
cysteine level was 10.8 µmol/L (range 5-
12). LDH was elevated - 18.54 ukat/L 
(range 0-5.73). Total bilirubin was 42.2 
µmol/L (range 0.01-21), direct bilirubin 9.1 
µmol/L (range 0-5) and indirect bilirubin 
33.3 µmol/L (range 0.01-16). Direct Co-
ombs test was negative. Serum vitamin 
B12 level was 61.2 pmol/L (range 138-
652) and serum folate level 34.5 nmol/L 
(range 7-45.3).The blood smear showed 
anisocytosis with regular white blood cells 
and platelets. A bone marrow aspiration 
showed morphological changes consistent 
with megaloblastic anaemia. Immunofeno-
typing revealed no pathological hemato-
poietic cells. Karyotype was normal. The 
echocardiographic finding was normal. 
The computerized tomography (CT) and 
magnetic resonance imaging (MRI) of the 
endocranium showed global parenchymal 
reductive changes with consecutive en-
largement of ventricles (Figs. 1, 2). Psy-
chological testing revealed a delay in psy-
chical development. 
During the hospitalization the child re-
ceived a transfusion of filtered red blood 
cells three times and a transfusion of pla-
telet concentrates two times. After B12 de-
ficiency was diagnosed, vitamin B12 the-
rapy started. Vitamin B12 in a dose of 10 
µg per kg was applied intramuscularly 
daily for 2 weeks, then once weekly. 
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Nutrition was initiated firstly through a 
nasogastric tube. In the further course the 
child began to accept meals. Three days 
after initiating B12 vitamin therapy there 
was an improvement in the blood count 
with the gradual improvement of neuro-
logical state and gaining in body weight. 
The child was discharged after a month of 
hospital treatment with a normal blood 
count and vitamin B12 value of more than 
1475 pmol/l. On the first ambulatory fol-
low-up, 3 weeks after hospitalization, due 
to the elevated vitamin B12 values, further 
therapy was not continued. The child be-
gan to sit a month after hospitalization, 
and after 3 months he stood. He was ac-
tive and in a good mood along with further 
gaining in body weight (Table 1). Control 
neuroradiological imaging was not con-
ducted because of good clinical response. 
DISCUSSION 
Vitamin B12 is a relatively large and com-
plex vitamin. It is an essential micro-
nutrient that plays a fundamental role in 
cell division and in one-carbon meta-
bolism. Vitamin B12 participates as a co-
factor in two important intracellular meta-
bolic reactions (Elmadfa and Singer,2009). 
Deoxyadenosylcobalamin, one of the co-
enzyme forms of cobalamin, is a cofactor 
for methionine synthase, the enzyme 
which converts homocysteine to methio-
nine (Roumeliotis et al., 2012). The me-
thionine synthase reaction is necessary for 
normal DNA synthesis (Elmadfa and Sin-
ger,2009). If this coenzyme is lacking, ho-
mo-cysteine accumulates, leading to me-
galoblastic anaemia and neurologic se-
quelae. Cobalamin is also a cofactor for 
methylmalonyl CoA mutase, the enzyme 
that converts methylmalonyl CoA to suc-
cinyl CoA, which plays an important role in 
the metabolism of odd-chain fatty acids 
and purine, and pyrimidine synthesis. Me-
thylmalonic aciduria and defective amino 
acid synthesis results from the lack of the 
cobalamin cofactor, clinically leading to 
pancytopenia, metabolic acidosis and hy-
potonia (Roumeliotis et al., 2012). 
Vitamin B12 is the only vitamin that is syn-
thesized exclusively by microorganisms. 
Dietary sources are primarily of animal ori-
gin, including meats, dairy products, and 
eggs. It is not supplied by plant foods un-
less they have been exposed to specific 
bacterial action. Thus, vegans and to a 
lesser degree other vegetarians are ad-
vised to use vitamin B12-fortified foods or 
supplements (Elmadfa and Singer, 2009; 
Stabler and Allen; 2004, Milankov, 2014; 
Kovač et al., 2013). 
Cobalamin is actively transported across 
the placenta in foetuses of cobalamin-
deficient mothers, and infants of such mo-
thers are haematologically normal at birth. 
However, their cobalamin stores are low 
and if they are exclusively breastfed, co-
balamin deficiency will develop between 2 
and 12 months of age, when stores have 
been depleted (Roumeliotis et al., 2012; 
Kocaoglu et al., 2014; Goraya et al., 2015; 
Pepper and Black, 2011; Zeeshan et al., 
2017). 
Infant vitamin B12 deficiency, in most 
cases, results from a maternal deficiency. 
Maternal causes of infant deficiency can 
be broadly divided into deficient maternal 
diet or maternal pernicious anaemia in a 
breastfed infant, because infant formulas 
are supplemented with B12. Other more 
rare causes in children include surgical re-
moval of the stomach and/or distal ileum, 
autoimmune gastritis, bacterial over-
growth, ileal disease (Crohn disease), exo-
crine pancreatic insufficiency, and Whipple 
disease. Maternal dietary deficiency is 
usually due to poverty, vegetarian diet 
(which excludes meat and fish) or vegan 
diet (excluding also all dairy and eggs) 
(Roumeliotis et al., 2012; Elmadfa and 
Singer, 2009; Stabler and Allen, 2004; 
Milankov, 2014; Weiss et al., 2004). Mo-
thers are often asymptomatic but have 
laboratory evidence of vitamin B12 de-
ficiency (Goraya et al., 2015; Guez et al., 
2012). In our patient vitamin B12 defi-
ciency was caused by insufficient intake of 
the vitamin due to exclusion of meat, eggs 
and milk in mother’s diet during pregnancy 
and lactation. In addition to that, the child 
aged 13 months was exclusively breastfed 
with no introduction of solid food, so 
breastmilk of a vegan mother, lacking vi-
tamin B12, was the only nutritional source. 
Clinical manifestations of vitamin B12 de-
ficiency in infants result from the affected 
hematopoietic, digestive and nervous sys-
tems. They include macrocytic anaemia, 
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pallor, weakness, lethargy, irritability, fe-
eding difficulties with aversion to or refusal 
of solid food, failure to thrive and neuro-
developmental regression (Roumeliotis et 
al., 2012; Goraya et al., 2015; Weiss et al., 
2004). All these symptoms were present in 
our patient. Other findings include glos-
sitis, vomiting, diarrhoea, icterus, oedema, 
convulsions, repeated infections, sudden 
nose bleed, bruises and petechiae without 
any history of trauma (Roumeliotis et al., 
2012; Goraya et al., 2015; Weiss et al., 
2004; Codazzi et al., 2005; Baatenburg et 
al. 2005; Reghu et al. 2005). Deficiency of 
vitamin B12 may affect the central nervous 
system and, in severe cases, cause brain 
atrophy (Kocaoglu et al., 2014; Goraya et 
al., 2015; Guez et al., 2012; Codazzi et al., 
2005; Wagnon et al. 2005). Head circum-
ference measurements fall off the growth 
curve, indicating slowing of brain growth. 
Patients progress to hypotonia with hyper-
reflexia, and exhibit abnormal movements 
such as tremor, myoclonus and cho-
reoathetoid movements (Roumeliotis et 
al., 2012; Codazzi et al., 2005; Goraya et 
al., 2015). Rarely this deficiency may 
cause coma, hypothermia and respiratory 
failure requiring ventilation. Neurodevelop-
mental regression may lead clinicians on 
the wrong path searching for neurodege-
nerative disorders or inborn errors of me-
tabolism resulting in unnecessary inves-
tigation and inappropriate delay in treat-
mentof vitamin B12 deficiency (Goraya et 
al., 2015).The mechanisms of central ner-
vous system involvement are not clearly 
understood. Demyelination, impaired me-
thylation and lactate accumulation in pe-
ripheral nerves, spinal cord and cerebrum 
have all been proposed (Roumeliotis et al., 
2012). Neurodevelopmental delay was 
present in our patient, while CT and MRI 
of the endocranium showed global paren-
chymal reductive changes. The haemato-
logical manifestation of vitamin B12 de-
ficiency is megaloblastic anaemia with 
high MCV and typical morphological featu-
res, such as large erythrocytes with aniso-
cytosis and poikilocytosis and hyperlobu-
lation of the nuclei of the granulocytes. In 
advanced cases, neutropaenia and throm-
bocytopaenia may occur; simulating ap-
lastic anaemia or leukaemia (Kocaoglu et 
al., 2014; Citak and Citak, 2011).The diag-
nosis of vitamin B12 deficiency is con-
firmed by determining serum vitamin B12 
concentration. In our patient a pancy-to-
paenia was detected. The diagnosis of 
megaloblastic anaemia was made based 
on high MCV and bone marrow biopsy 
findings. Low serum vitamin B12 con-
firmed vitamin B12 deficiency. 
Treatment of vitamin B12 deficiency 
should start as soon as possible, because 
the neurological sequelae can be cor-
rected. Most clinical features of vitamin 
B12 deficiency resolve quickly with re-
pletion of vitamin B12 (Weiss et al., 2004; 
Guez et al., 2012). This was confirmed in 
our case where three days after initiating 
B12 vitamin therapy an improvement in 
the blood count and neurological state was 
detected. The neurologic findings gene-
rally improve within weeks, and MRI of the 
brain returns to normal within a few 
months. Long-term neurodeficit such as 
psychomotor and linguistic delay have 
been reported (Roumeliotis et al., 2012; 
Goraya et al., 2015; Codazzi et al., 2005). 
The overall prognosis depends on duration 
of deficiency and severity of symptoms 
rather than serum levels of vitamin B12 or 
haemoglobin values on admission. It 
seems that infants diagnosed and treated 
before one year of age have more fa-
vourable neurological outcome than those 
treated at a later period (Kocaoglu et al., 
2014). 
There are recommendations for initial and 
maintenance therapy of vitamin B12 de-
ficiency in adults but no clear guidelines 
are available for children. In adults with 
severe B12 deficiency with neurologic ma-
nifestations, experts recommend 1000 μg 
cyanocobalamin given via intramuscular 
injection daily for a week, followed by 
weekly injections for a month, then every 
third month. Consensus guidelines for op-
timal replacement therapy in deficient pae-
diatric patients are required. Replacement 
therapy at adult doses was described in a 
number of articles (Roumeliotis et al., 
2012; Kocaoglu et al., 2014; Guez et al., 
2012; Baatenburg et al. 2005; Citak and 
Citak, 2011). In our patient, vitamin B12 
was given in the dose 10 µg/kg daily for 2 
weeks, then weekly for a month. Then the 
therapy was stopped because of the high 
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Nutrition was initiated firstly through a 
nasogastric tube. In the further course the 
child began to accept meals. Three days 
after initiating B12 vitamin therapy there 
was an improvement in the blood count 
with the gradual improvement of neuro-
logical state and gaining in body weight. 
The child was discharged after a month of 
hospital treatment with a normal blood 
count and vitamin B12 value of more than 
1475 pmol/l. On the first ambulatory fol-
low-up, 3 weeks after hospitalization, due 
to the elevated vitamin B12 values, further 
therapy was not continued. The child be-
gan to sit a month after hospitalization, 
and after 3 months he stood. He was ac-
tive and in a good mood along with further 
gaining in body weight (Table 1). Control 
neuroradiological imaging was not con-
ducted because of good clinical response. 
DISCUSSION 
Vitamin B12 is a relatively large and com-
plex vitamin. It is an essential micro-
nutrient that plays a fundamental role in 
cell division and in one-carbon meta-
bolism. Vitamin B12 participates as a co-
factor in two important intracellular meta-
bolic reactions (Elmadfa and Singer,2009). 
Deoxyadenosylcobalamin, one of the co-
enzyme forms of cobalamin, is a cofactor 
for methionine synthase, the enzyme 
which converts homocysteine to methio-
nine (Roumeliotis et al., 2012). The me-
thionine synthase reaction is necessary for 
normal DNA synthesis (Elmadfa and Sin-
ger,2009). If this coenzyme is lacking, ho-
mo-cysteine accumulates, leading to me-
galoblastic anaemia and neurologic se-
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methylmalonyl CoA mutase, the enzyme 
that converts methylmalonyl CoA to suc-
cinyl CoA, which plays an important role in 
the metabolism of odd-chain fatty acids 
and purine, and pyrimidine synthesis. Me-
thylmalonic aciduria and defective amino 
acid synthesis results from the lack of the 
cobalamin cofactor, clinically leading to 
pancytopenia, metabolic acidosis and hy-
potonia (Roumeliotis et al., 2012). 
Vitamin B12 is the only vitamin that is syn-
thesized exclusively by microorganisms. 
Dietary sources are primarily of animal ori-
gin, including meats, dairy products, and 
eggs. It is not supplied by plant foods un-
less they have been exposed to specific 
bacterial action. Thus, vegans and to a 
lesser degree other vegetarians are ad-
vised to use vitamin B12-fortified foods or 
supplements (Elmadfa and Singer, 2009; 
Stabler and Allen; 2004, Milankov, 2014; 
Kovač et al., 2013). 
Cobalamin is actively transported across 
the placenta in foetuses of cobalamin-
deficient mothers, and infants of such mo-
thers are haematologically normal at birth. 
However, their cobalamin stores are low 
and if they are exclusively breastfed, co-
balamin deficiency will develop between 2 
and 12 months of age, when stores have 
been depleted (Roumeliotis et al., 2012; 
Kocaoglu et al., 2014; Goraya et al., 2015; 
Pepper and Black, 2011; Zeeshan et al., 
2017). 
Infant vitamin B12 deficiency, in most 
cases, results from a maternal deficiency. 
Maternal causes of infant deficiency can 
be broadly divided into deficient maternal 
diet or maternal pernicious anaemia in a 
breastfed infant, because infant formulas 
are supplemented with B12. Other more 
rare causes in children include surgical re-
moval of the stomach and/or distal ileum, 
autoimmune gastritis, bacterial over-
growth, ileal disease (Crohn disease), exo-
crine pancreatic insufficiency, and Whipple 
disease. Maternal dietary deficiency is 
usually due to poverty, vegetarian diet 
(which excludes meat and fish) or vegan 
diet (excluding also all dairy and eggs) 
(Roumeliotis et al., 2012; Elmadfa and 
Singer, 2009; Stabler and Allen, 2004; 
Milankov, 2014; Weiss et al., 2004). Mo-
thers are often asymptomatic but have 
laboratory evidence of vitamin B12 de-
ficiency (Goraya et al., 2015; Guez et al., 
2012). In our patient vitamin B12 defi-
ciency was caused by insufficient intake of 
the vitamin due to exclusion of meat, eggs 
and milk in mother’s diet during pregnancy 
and lactation. In addition to that, the child 
aged 13 months was exclusively breastfed 
with no introduction of solid food, so 
breastmilk of a vegan mother, lacking vi-
tamin B12, was the only nutritional source. 
Clinical manifestations of vitamin B12 de-
ficiency in infants result from the affected 
hematopoietic, digestive and nervous sys-
tems. They include macrocytic anaemia, 
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pallor, weakness, lethargy, irritability, fe-
eding difficulties with aversion to or refusal 
of solid food, failure to thrive and neuro-
developmental regression (Roumeliotis et 
al., 2012; Goraya et al., 2015; Weiss et al., 
2004). All these symptoms were present in 
our patient. Other findings include glos-
sitis, vomiting, diarrhoea, icterus, oedema, 
convulsions, repeated infections, sudden 
nose bleed, bruises and petechiae without 
any history of trauma (Roumeliotis et al., 
2012; Goraya et al., 2015; Weiss et al., 
2004; Codazzi et al., 2005; Baatenburg et 
al. 2005; Reghu et al. 2005). Deficiency of 
vitamin B12 may affect the central nervous 
system and, in severe cases, cause brain 
atrophy (Kocaoglu et al., 2014; Goraya et 
al., 2015; Guez et al., 2012; Codazzi et al., 
2005; Wagnon et al. 2005). Head circum-
ference measurements fall off the growth 
curve, indicating slowing of brain growth. 
Patients progress to hypotonia with hyper-
reflexia, and exhibit abnormal movements 
such as tremor, myoclonus and cho-
reoathetoid movements (Roumeliotis et 
al., 2012; Codazzi et al., 2005; Goraya et 
al., 2015). Rarely this deficiency may 
cause coma, hypothermia and respiratory 
failure requiring ventilation. Neurodevelop-
mental regression may lead clinicians on 
the wrong path searching for neurodege-
nerative disorders or inborn errors of me-
tabolism resulting in unnecessary inves-
tigation and inappropriate delay in treat-
mentof vitamin B12 deficiency (Goraya et 
al., 2015).The mechanisms of central ner-
vous system involvement are not clearly 
understood. Demyelination, impaired me-
thylation and lactate accumulation in pe-
ripheral nerves, spinal cord and cerebrum 
have all been proposed (Roumeliotis et al., 
2012). Neurodevelopmental delay was 
present in our patient, while CT and MRI 
of the endocranium showed global paren-
chymal reductive changes. The haemato-
logical manifestation of vitamin B12 de-
ficiency is megaloblastic anaemia with 
high MCV and typical morphological featu-
res, such as large erythrocytes with aniso-
cytosis and poikilocytosis and hyperlobu-
lation of the nuclei of the granulocytes. In 
advanced cases, neutropaenia and throm-
bocytopaenia may occur; simulating ap-
lastic anaemia or leukaemia (Kocaoglu et 
al., 2014; Citak and Citak, 2011).The diag-
nosis of vitamin B12 deficiency is con-
firmed by determining serum vitamin B12 
concentration. In our patient a pancy-to-
paenia was detected. The diagnosis of 
megaloblastic anaemia was made based 
on high MCV and bone marrow biopsy 
findings. Low serum vitamin B12 con-
firmed vitamin B12 deficiency. 
Treatment of vitamin B12 deficiency 
should start as soon as possible, because 
the neurological sequelae can be cor-
rected. Most clinical features of vitamin 
B12 deficiency resolve quickly with re-
pletion of vitamin B12 (Weiss et al., 2004; 
Guez et al., 2012). This was confirmed in 
our case where three days after initiating 
B12 vitamin therapy an improvement in 
the blood count and neurological state was 
detected. The neurologic findings gene-
rally improve within weeks, and MRI of the 
brain returns to normal within a few 
months. Long-term neurodeficit such as 
psychomotor and linguistic delay have 
been reported (Roumeliotis et al., 2012; 
Goraya et al., 2015; Codazzi et al., 2005). 
The overall prognosis depends on duration 
of deficiency and severity of symptoms 
rather than serum levels of vitamin B12 or 
haemoglobin values on admission. It 
seems that infants diagnosed and treated 
before one year of age have more fa-
vourable neurological outcome than those 
treated at a later period (Kocaoglu et al., 
2014). 
There are recommendations for initial and 
maintenance therapy of vitamin B12 de-
ficiency in adults but no clear guidelines 
are available for children. In adults with 
severe B12 deficiency with neurologic ma-
nifestations, experts recommend 1000 μg 
cyanocobalamin given via intramuscular 
injection daily for a week, followed by 
weekly injections for a month, then every 
third month. Consensus guidelines for op-
timal replacement therapy in deficient pae-
diatric patients are required. Replacement 
therapy at adult doses was described in a 
number of articles (Roumeliotis et al., 
2012; Kocaoglu et al., 2014; Guez et al., 
2012; Baatenburg et al. 2005; Citak and 
Citak, 2011). In our patient, vitamin B12 
was given in the dose 10 µg/kg daily for 2 
weeks, then weekly for a month. Then the 
therapy was stopped because of the high 
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serum level of vitamin B12. Further clinical 
observation included control blood counts 
and determination of serum level of vita-
min B12.   
CONCLUSIONS 
Vitamin B12 deficiency is a treatable 
cause of pancytopenia and neurological 
dysfunction in children and should be 
considered as differential diagnosis in an 
infant with neurological symptoms, es-
pecially if megaloblastic anaemia is pre-
sent. In order to prevent it, clinician’s ca-
ring for pregnant or lactating mothers and 
their newborns should take a full dietary 
history and consider vitamin B12 status. In 
pregnant and breastfeeding women on a 
vegetarian or vegan diet B12 supplements 
should be recommended. Our case high-
lights the need to carefully plan the diet 
and use a supplementation during the 
pregnancy and lactation either in ve-
getarian or vegan mothers in order to pre-
vent negative health repercussion to both 
a mother and her child.  
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serum level of vitamin B12. Further clinical 
observation included control blood counts 
and determination of serum level of vita-
min B12.   
CONCLUSIONS 
Vitamin B12 deficiency is a treatable 
cause of pancytopenia and neurological 
dysfunction in children and should be 
considered as differential diagnosis in an 
infant with neurological symptoms, es-
pecially if megaloblastic anaemia is pre-
sent. In order to prevent it, clinician’s ca-
ring for pregnant or lactating mothers and 
their newborns should take a full dietary 
history and consider vitamin B12 status. In 
pregnant and breastfeeding women on a 
vegetarian or vegan diet B12 supplements 
should be recommended. Our case high-
lights the need to carefully plan the diet 
and use a supplementation during the 
pregnancy and lactation either in ve-
getarian or vegan mothers in order to pre-
vent negative health repercussion to both 
a mother and her child.  
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